1. Summary Information

 

 

Country

India

Company Name

VHB MEDI SCIENCES LIMITED

Principal Name 1

Mr. Uttam Keshrimal Jain

Status

Moderate

Principal Name 2

Mr. Ashok Keshrimal Jain

 

 

Registration #

11-174054

Street Address

103, Bhag Co-Operative Society, 1st Floor, Plot No. 29, Sector-14, Vashi, New Mumbai – 400703, Maharashtra, India

Established Date

12.09.2007

SIC Code

--

Telephone#

91-22-67739000

Business Style 1

Manufacturing

Fax #

91-22-67739100/ 67739000

Business Style 2

Marketing

Homepage

www.vhbmedisciences.com

Product Name 1

Drug

# of employees

Not Available

Product Name 2

Pharmaceutical Products

Paid up capital

Rs.127,500,000/-

Product Name 3

--

Shareholders

Bodies corporate - 99.98%

Other top fifty shareholders - 0.02%

Banking

Bank of Baroda

Public Limited Corp.

NO

Business Period

6 Years

IPO

NO

International Ins.

-

Public Enterprise

NO

Rating

Ca (11)

Related Company

Relation

Country

Company Name

CEO

Holding Company

India

Neon Laboratories Limited

--

Note

-

 

2. Summary Financial Statement

Balance Sheet as of

31.03.2012

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

124,799,000

Current Liabilities

66,867,000

Inventories

105,170,000

Long-term Liabilities

1,320,263,000 

Fixed Assets

1,252,751,000

Other Liabilities

538,000

Deferred Assets

0,000

Total Liabilities

1,387,668,000

Invest& other Assets

150,000

Retained Earnings

(32,298,000)

 

 

Net Worth

95,202,000

Total Assets

1,482,870,000

Total Liab. & Equity

1,482,870,000

 Total Assets

(Previous Year)

1,681,488,000

 

 

P/L Statement as of

31.03.2012

(Unit: Indian Rs.)

Sales

367,750,000

Net Profit

(103,707,000)

Sales(Previous yr)

664,250,000

Net Profit(Prev.yr)

(204,811,000)

MIRA INFORM REPORT

 

 

Report Date :

17.09.2013

 

IDENTIFICATION DETAILS

 

Name :

VHB MEDI SCIENCES LIMITED

 

 

Registered Office :

103, Bhag Co-Operative Society, 1st Floor, Plot No. 29, Sector-14, Vashi, New Mumbai – 400703, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

12.09.2007

 

 

Com. Reg. No.:

11-174054

 

 

Capital Investment / Paid-up Capital :

Rs.127.500 Millions

 

 

CIN No.:

[Company Identification No.]

U24232MH2007PLC174054

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMV15377F

 

 

PAN No.:

[Permanent Account No.]

AACCV5903E

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturing and Marketing of Drug and Pharmaceutical Products.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (11)

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

There appears delay in repayment of term loan.

 

Company has incurred loss from past two years. Overall financials appears to be below average.

 

Trade relations are fair. Business is active. Payment terms are slow.

 

The company can be considered for business dealings on a safe and secured trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

We are living in a world where volatility and uncertainty have become the New Normal. We saw a change of government in countries like Tunisia, Egypt, Libya and Vietnam. Once powerful countries in Europe are now fighting for bankruptcy. We have taken growth in the developing part of the world for granted but economic growth in China and India has begun to slow. Companies that were synonymous with their product categories just a few years ago are now no longer in existence. Kodak, the inventor of the digital camera had to wind up its operations, HMV, the British entertainment retailing company and Borders, once the second largest bookstore have shut down due to their inability to evolve their business models with the changing time. Readers’ Digest, Thomson Register are no more !

 

There is another megatrend happening. The World order is changing as economic power shifts from West to East. According to McKinsey study, it took Britain more than 100 years to double its economic output per person during its industrial revolution and the US later took more than 50 years to do the same. More than a century later, China and India have doubled their GDP per capital in 12 and 18 years respectively. By 2020, emerging Asia will become the world’s largest consuming block, overtaking North America.

 

The years after the outbreak of the global financial crisis, the world economy continues to remain fragile. The Indian economy demonstrated remarkable resilience in the initial years of the contagion but finally lost ground last year. GDP growth slowed down. Currency has been weakening. There is a marked deceleration in agriculture, industry and services. Dampening sentiment led to a cut-back in investment as well as private consumption expenditure.  Inflation remained at high levels fuelled by the pressure from the food and fuel sectors. The large fiscal and current account deficit s continued to cause grave concern. It is imperative that India regains its growth trajectory of 8-9 % sooner than later. This is crucially important given the need to create gainful livelihood opportunities for the millions living in poverty as also the large contingent of young people joining the job market every year.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office :

103, Bhag Co-Operative Society, 1st Floor, Plot No. 29, Sector-14, Vashi, New Mumbai – 400703, Maharashtra, India

Tel. No.:

91-22-67739000

Fax No.:

91-22-67739100/ 67739000

E-Mail :

mukesh.jain@vhbgroup.com

accounts@vhbgroup.com

Website :

www.vhbmedisciences.com

 

 

Corporate Office :

T – 351, 5th Floor, Tower No. 8, Belapur Railway Station Complex, Navi Mumbai 400614 Maharashtra, India

Tel. No.:

91-22-67739000

Fax No.:

91-22-67739100

E-Mail :

vipul.bhagat@vhbgroup.com

Website :

www.vhbgroupup.com

 

 

DIRECTORS

 

As on: 13.09.2012

 

Name :

Mr. Uttam Keshrimal Jain

Designation :

Additional Director

Address :

2005, Kent Gardens, TPS III, Factory Lane, Borivali (West), Mumbai – 400092, Maharashtra, India 

Date of Birth/Age :

05.02.1954

Date of Appointment :

27.09.2012

DIN No.:

00205866

 

 

Name :

Mr. Ashok Keshrimal Jain

Designation :

Additional Director

Address :

504-505, Kent Gardens, TPS III, Factory Lane, Borivali (West), Mumbai – 400092, Maharashtra, India 

Date of Birth/Age :

13.09.1957

Date of Appointment :

27.09.2012

DIN No.:

00205810

 

 

Name :

Mr. Pravin Keshrimal Jain

Designation :

Additional Director

Address :

502, Mohan Palace, TPS III, Factory Lane, Borivali (West), Mumbai – 400092, Maharashtra, India 

Date of Birth/Age :

18.03.1964

Date of Appointment :

27.09.2012

DIN No.:

00205927

 

 

Name :

Mr. Rahul Ashok Jain

Designation :

Additional Director

Address :

504-505, Kent Gardens, TPS III, Factory Lane, Borivali (West), Mumbai – 400092, Maharashtra, India 

Date of Birth/Age :

26.04.1984

Date of Appointment :

27.09.2012

DIN No.:

01304110

Other Directorship :

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 13.09.2012

 

Names of Shareholders

 

No. of Shares

Neon Laboratories Limited, India

 

12746960

Uttam Keshrimal Jain

 

100

Ashok Keshrimal Jain

 

100

Uttam K Jain (HUF)

 

90

Ashok K Jain (HUF)

 

85

Pravin Keshrimal Jain

 

1665

Pravin K Jain (HUF)

 

1000

 

 

 

Total

 

12750000

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 13.09.2012

 

Category

 

Percentage

 

 

 

Bodies corporate

 

99.98

Other top fifty shareholderss

 

0.02

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Marketing of Drug and Pharmaceutical Products.

 

 

Products :

Product Products

ITC Code

Medicines

30041090

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         Bank of Baroda, Worli Branch, 135, C.D.C. Building, Dr. A. B. Road, Worli,  Mumbai - 400018, Maharashtra, India

·         State Bank of India

·         Axis Bank Limited

·         Union Bank

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2012

As on

31.03.2011

LONG-TERM BORROWINGS

 

 

Rupee term loans from banks

(Secured against fixed assets and against Hypothecation of Stocks and Book debts assets of the company)

800.363

760.473

Working capital loans from banks

(Secured against Hypothecation of Stocks and Book debts with extended charge on all fixed)

98.521

135.412

Other loans and advances

(Secured Against vehicle financed)

0.212

0.448

 

 

 

Total

899.096

896.333

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Janak Majethia and Associates

Chartered Accountants

Address :

Chandaramji Building, R No. 25, Plot No 109/110, 7-A Sewri Wadala Road, Wadala, Mumbai  - 400031, Maharashtra, India

PAN No.:

AFLPM0208A

 

 

Holding Company :

Neon Laboratories Limited

CIN No.: U24100MH1982PLC027493

 

 

Related Parties :

VHB Lifesciences Limited

CIN No.:U74900MH2007PLC171648

 

 

CAPITAL STRUCTURE

 

As on: 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

15000000

Equity Shares

Rs.10/- each

Rs.150.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

12750000

Equity Shares

Rs.10/- each

Rs.127.500 Millions

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

127.500

127.500

(b) Reserves & Surplus

 

(32.298)

71.409

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

95.202

198.909

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

1320.263

1264.967

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

1320.263

1264.967

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

56.404

195.931

(c) Other current liabilities

 

10.463

20.213

(d) Short-term provisions

 

0.538

1.468

Total Current Liabilities (4)

 

67.405

217.612

 

 

 

 

TOTAL

 

1482.870

1681.488

 

 

 

 

ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

1252.751

948.520

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

0.000

299.588

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.150

0.150

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

0.000

0.000

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

1252.901

1248.258

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

105.170

137.032

(c) Trade receivables

 

35.783

202.067

(d) Cash and cash equivalents

 

32.387

25.000

(e) Short-term loans and advances

 

56.629

69.131

(f) Other current assets

 

0.000

0.000

Total Current Assets

 

229.969

433.230

 

 

 

 

TOTAL

 

1482.870

1681.488

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

127.500

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

276.221

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

403.721

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

819.201

2] Unsecured Loans

 

 

356.934

TOTAL BORROWING

 

 

1176.135

DEFERRED TAX LIABILITIES

 

 

0.000

 

 

 

 

TOTAL

 

 

1579.856

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

409.986

Capital work-in-progress

 

 

740.893

 

 

 

 

INVESTMENT

 

 

0.150

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
 
224.420

 

Sundry Debtors

 
 
648.102

 

Cash & Bank Balances

 
 
13.254

 

Other Current Assets

 
 
0.000

 

Loans & Advances

 
 
52.215

Total Current Assets

 
 
937.991

Less : CURRENT LIABILITIES & PROVISIONS

 
 
 

 

Sundry Creditors

 
 
450.985

 

Other Current Liabilities

 
 
26.924

 

Provisions

 
 
31.255

Total Current Liabilities

 
 
509.164

Net Current Assets

 
 
428.827

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

1579.856

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

367.750

664.250

1189.958

 

 

Other Income

85.530

2.001

2.450

 

 

TOTAL                                     (A)

453.280

666.251

1192.408

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

239.062

344.255

 

 

Changes in inventories of finished goods, work-in-progress and stock-in-trade

12.988

103.300

 

 

 

Employee benefit expense

37.738

33.773

 

 

 

Other expenses

80.541

199.929

 

 

 

TOTAL                                     (B)

370.329

681.257

946.160

 

 

 

 

 

Less

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

82.951

(15.006)

246.248

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

144.965

139.501

80.537

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

62.014

(154.507)

165.711

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

41.720

41.322

16.477

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX (E-F)                (G)

(103.734)

(195.829)

149.234

 

 

 

 

 

Less

TAX                                                                  (H)

(0.027)

8.982

143.243

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX (G-H)                   (I)

(103.707)

(204.811)

5.991

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

24.248

45.601

NA

 

 

 

 

 

 

TOTAL IMPORTS

64.564

121.859

138.516

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

(8.13)

(16.06)

11.69

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

(22.88)

(30.74)

0.50

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

(28.21)

(29.48)

12.54

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(7.00)

(14.17)

11.07

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(1.09)

(0.98)

0.37

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

13.87

6.36

2.91

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

3.41

1.99

1.84

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

UNSECURED LOAN

(Rs. In Millions)

Particular

As on

31.03.2012

As on

31.03.2011

LONG-TERM BORROWINGS

 

 

Loans repayable on demand

356.737

304.134

Loans and advances from related parties

64.430

64.500

Total

421.167

368.634

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10258353

23/10/2010

20,000,000.00

Bank of Baroda

WORLI BRANCH, 135, C.D.C. BUILDING, DR. ANNIE BESANT ROAD, WORLI, MUMBAI, MAHARASHTRA - 400018, INDIA

B01003698

2

10200373

19/12/2009

715,000.00

Bank of Baroda

WORLI BRANCH, 135, C.D.C. BUILDING, DR. A. B. ROAD, WORLI, MUMBAI, MAHARASHTRA - 400018, INDIA

A78745171

3

10173720

11/07/2009

30,000,000.00

Bank of Baroda

WORLI BRANCH, 135, C.D.C. BUILDING,, DR. ANNIE BESANT ROAD, WORLI, MUMBAI, MAHARASHTRA - 400018, INDIA

A68203868

4

10155426

11/01/2011 *

1,163,400,000.00

Bank of Baroda

WORLI BRANCH, 135, C.D.C. BUILDING,, DR. ANNIE BESANT ROAD, WORLI, MUMBAI, MAHARASHTRA

B07058316

5

10155427

11/01/2011 *

1,163,400,000.00

Bank of Baroda

WORLI BRANCH, 135, C.D.C. BUILDING,, DR. ANNIE BESANT ROAD, WORLI, MUMBAI, MAHARASHTRA

B07058415

6

10113095

07/06/2008

641,000,000.00

BANK OF BARODA

WORLI BRANCH, 135, CDC BUILDING, DR. ANNIE BESANT ROAD, WORLI, MUMBAI, MAHARASHTRA - 400018, INDIA

A40606055

 

* Date of charge modification

 

 

FIXED ASSETS

 

Tangible Assets

·         Land

·         Building

·         Plant and Equipment

·         Factory Equipments

·         Furniture and Fixtures

·         Vehicles

·         Office Equipment

·         Computer Equipments

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.48

UK Pound

1

Rs.99.66

Euro

1

Rs.83.50

 

 

INFORMATION DETAILS

 

Report Prepared by :

VRN

 


SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

1

PAID-UP CAPITAL

1~10

2

OPERATING SCALE

1~10

2

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

1

--PROFITABILIRY

1~10

1

--LIQUIDITY

1~10

1

--LEVERAGE

1~10

1

--RESERVES

1~10

1

--CREDIT LINES

1~10

1

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

11

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.